Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival

by S. Rudisile, A. Gosewisch, V. Wenter, M. Unterrainer, G. Böning, F. J. Gildehaus, W. P. Fendler, C. J. Auernhammer, C. Spitzweg, P. Bartenstein, A. Todica, H. Ilhan
Published 2019-08-01

Salvage therapies for PSMA PET-positive nodal recurrent prostate cancer

by A. Kretschmer, A. Buchner, C. Eze, P. Rogowski, C. Schäfer, H. Ilhan, M. Li, W.P. Fendler, P. Bartenstein, U. Ganswindt, C.G. Stief, C. Belka, N. Schmidt-Hegemann
Published 2020-07-01

Recent advances of PET imaging in clinical radiation oncology

by M. Unterrainer, C. Eze, H. Ilhan, S. Marschner, O. Roengvoraphoj, N. S. Schmidt-Hegemann, F. Walter, W. G. Kunz, P. Munck af Rosenschöld, R. Jeraj, N. L. Albert, A. L. Grosu, M. Niyazi, P. Bartenstein, C. Belka
Published 2020-04-01